Remaining FDA PDUFA Drug Approval Dates in 2024.
- Published in:
- American Health & Drug Benefits, 2024, v. 17, p. 26
- Publication type:
- Article
Works matching IS 19422962 AND DT 2024 AND VI 17
Results: 7
1
2
Imdelltra Approved for Treatment of Extensive-Stage Small Cell Lung Cancer on or Following Disease Progression While on Platinum-Based Chemotherapies.
- Published in:
- American Health & Drug Benefits, 2024, v. 17, p. 19
- By:
- Publication type:
- Article
3
Directory of Novel FDA Approvals, 2024.
- Published in:
- American Health & Drug Benefits, 2024, v. 17, p. 22
- Publication type:
- Article
4
Ongoing Analyses and Recent Data for Talvey in Multiple Myeloma.
- Published in:
- American Health & Drug Benefits, 2024, v. 17, p. 16
- By:
- Publication type:
- Article
5
Bispecific Antibody Columvi Offering Option in Diffuse Large B-cell Lymphoma Treatment.
- Published in:
- American Health & Drug Benefits, 2024, v. 17, p. 13
- By:
- Publication type:
- Article
6
Epkinly Receives Accelerated Approval for Treatment of Follicular Lymphoma After ≥2 Lines of Systemic Therapy.
- Published in:
- American Health & Drug Benefits, 2024, v. 17, p. 10
- By:
- Publication type:
- Article
7
Welcome to Our Latest Installment of the Payers' Guide to FDA Updates.
- Published in:
- American Health & Drug Benefits, 2024, v. 17, p. 8
- Publication type:
- Article